BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) Forecast, Price Target & Analyst Ratings

BIT:1BMRN • US09061G1013

Current stock price

48.12 EUR
-2.58 (-5.09%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOMARIN PHARMACEUTICAL INC (1BMRN.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€80.11
+ 66.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 25, 2026
Period
Q4 / 2025
EPS Estimate
$0.61
Revenue Estimate
843.89M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.88%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€80.11
Upside
+ 66.47%
From current price of €48.12 to mean target of €80.11, Based on 32 analyst forecasts
Low
€51.96
Median
€82.64
High
€109.83

Price Target Revisions

1 Month
-2.74%
3 Months
-2.74%

Price Target Summary

32 Wall Street analysts provided a forecast for the next 12 months for 1BMRN.MI. The average price target is 80.11 EUR. This implies a price increase of 66.47% is expected in the next year compared to the current price of 48.12.
The average price target has been revised downward by 2.74% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1BMRN Current Analyst Rating1BMRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10

Analyst Ratings History

1BMRN Historical Analyst Ratings1BMRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
81.88%
1BMRN.MI was analyzed by 32 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about 1BMRN.MI.
In the previous month the buy percentage consensus was at a similar level.
1BMRN.MI was analyzed by 32 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 25, 2026
Period
Q4 / 2025
EPS Estimate
$0.61
Revenue Estimate
843.89M
Revenue Q2Q
12.92%
EPS Q2Q
-3.91%
Number of Analysts
27

Next Earnings Revisions

Revenue (1 Month)
0.68%
Revenue (3 Months)
0.77%
EPS (1 Month)
-29.03%
EPS (3 Months)
-24.43%

Next Earnings Summary

1BMRN.MI is expected to report earnings on 2/25/2026. The consensus EPS estimate for the next earnings is 0.61 EUR and the consensus revenue estimate is 843.89M EUR.
The next earnings revenue estimate has been revised upward by 0.77% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
1BMRN.MI revenue by date.1BMRN.MI revenue by date.
2.096B
13.52%		2.419B
15.42%		2.854B
17.97%		3.239B
13.49%		3.554B
9.73%		3.907B
9.93%		3.945B
0.97%		4.076B
3.32%		4.226B
3.68%		4.072B
-3.64%		4.084B
0.29%		4.142B
1.42%
EBITDA
YoY % growth
1BMRN.MI ebitda by date.1BMRN.MI ebitda by date.
166.6M
588.43%		290.16M
74.17%		666.468M
129.69%		698.9M
4.87%		1.125B
60.97%		1.276B
13.42%		1.141B
-10.58%		1.288B
12.88%		1.404B
9.01%		1.471B
4.77%		1.477B
0.41%		N/A
EBIT
YoY % growth
1BMRN.MI ebit by date.1BMRN.MI ebit by date.
64.6M
177.09%		185.774M
187.58%		570.042M
206.85%		661.87M
16.11%		1.092B
64.99%		1.368B
25.27%		1.269B
-7.24%		1.454B
14.58%		1.62B
11.42%		1.531B
-5.49%		1.498B
-2.16%		1.503B
0.33%
Operating Margin
1BMRN.MI operating margin by date.1BMRN.MI operating margin by date.
3.08%7.68%19.97%20.43%30.73%35.01%32.17%35.67%38.33%37.60%36.68%36.29%
EPS
YoY % growth
1BMRN.MI eps by date.1BMRN.MI eps by date.
0.29
180.56%		0.95
227.59%		2.21
132.63%		2.83
28.21%		4.64
63.90%		5.49
18.25%		6.95
26.49%		7.65
10.13%		7.72
0.87%		7.08
-8.26%		7.10
0.24%		7.23
1.92%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.61
-3.91%		1.08
14.10%		1.10
-10.36%		1.25
880.17%		1.29
109.16%
Revenue
Q2Q % growth		843.89M
12.92%		837.25M
12.36%		862.55M
4.50%		912.01M
17.51%		937.65M
11.11%
EBITDA
Q2Q % growth		138M
-48.44%		256.85M
4.43%		286.52M
-9.76%		266.32M
2,043.08%		282.23M
104.51%
EBIT
Q2Q % growth		172.44M
0.70%		252.43M
12.75%		263.14M
-4.96%		296.99M
736.06%		317.81M
84.30%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1BMRN.MI Yearly Revenue VS Estimates1BMRN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
1BMRN.MI Yearly EPS VS Estimates1BMRN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
35.45%
EPS Next 5 Year
28.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.75%
Revenue Next 5 Year
7.22%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
41.17%
EBIT Next 5 Year
23.21%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIOMARIN PHARMACEUTICAL INC / 1BMRN.MI Forecast FAQ

What do analysts expect the price target to be for BIOMARIN PHARMACEUTICAL INC (1BMRN.MI)?

32 analysts have analysed 1BMRN.MI and the average price target is 80.11 EUR. This implies a price increase of 66.47% is expected in the next year compared to the current price of 48.12.

What is the next earnings date for 1BMRN stock?

BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) will report earnings on 2026-02-25, after the market close.

What are the consensus estimates for 1BMRN stock next earnings?

The consensus EPS estimate for the next earnings of BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) is 0.61 EUR and the consensus revenue estimate is 843.89M EUR.

How many analysts cover BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) stock?

The number of analysts covering BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) is 32.